These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24040246)

  • 1. Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeys.
    Campello L; Esteve-Rudd J; Bru-Martínez R; Herrero MT; Fernández-Villalba E; Cuenca N; Martín-Nieto J
    PLoS One; 2013; 8(9):e74439. PubMed ID: 24040246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease.
    Mandel S; Grünblatt E; Youdim M
    J Neural Transm Suppl; 2000; (60):117-24. PubMed ID: 11205134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR
    J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.
    Pattarini R; Smeyne RJ; Morgan JI
    Neuroscience; 2007 Mar; 145(2):654-68. PubMed ID: 17258864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC; Gimenez-Cassina A; Lim F; Díaz-Nido J
    J Neurosci Res; 2010 Jul; 88(9):1943-50. PubMed ID: 20143419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.
    Masilamoni GJ; Bogenpohl JW; Alagille D; Delevich K; Tamagnan G; Votaw JR; Wichmann T; Smith Y
    Brain; 2011 Jul; 134(Pt 7):2057-73. PubMed ID: 21705423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Cho KI; Searle K; Webb M; Yi H; Ferreira PA
    Cell Mol Life Sci; 2012 Oct; 69(20):3511-27. PubMed ID: 22821000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of SIRT5 against motor deficit and dopaminergic degeneration in MPTP-induced mice model of Parkinson's disease.
    Liu L; Peritore C; Ginsberg J; Shih J; Arun S; Donmez G
    Behav Brain Res; 2015 Mar; 281():215-21. PubMed ID: 25541039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
    Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
    Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by alpha-synuclein.
    Cano-Jaimez M; Pérez-Sánchez F; Milán M; Buendía P; Ambrosio S; Fariñas I
    Neurobiol Dis; 2010 Apr; 38(1):92-103. PubMed ID: 20079841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson's disease.
    Cuenca N; Herrero MT; Angulo A; de Juan E; Martínez-Navarrete GC; López S; Barcia C; Martín-Nieto J
    J Comp Neurol; 2005 Dec; 493(2):261-73. PubMed ID: 16255027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism.
    Annese V; Herrero MT; Di Pentima M; Gomez A; Lombardi L; Ros CM; De Pablos V; Fernandez-Villalba E; De Stefano ME
    Brain Struct Funct; 2015 Mar; 220(2):703-27. PubMed ID: 24558048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
    Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
    Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
    Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA; Morin N; Grégoire L; Morissette M; Di Paolo T
    J Neurosurg; 2015 Dec; 123(6):1383-93. PubMed ID: 25932606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.
    Ghilardi MF; Chung E; Bodis-Wollner I; Dvorzniak M; Glover A; Onofrj M
    Life Sci; 1988; 43(3):255-62. PubMed ID: 3260986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.